Fentanyl as an Adjuvant to Peribulbar Block in Buckle or Squint Surgeries

NCT05539911 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-10-25

No results posted yet for this study

Summary

The use of fentanyl as an adjuvant to local anesthetic mixture in many regional blocks. It was effective when used in peribulbar block in cataract and vitreoretinal surgeries.

Our study will assess its efficacy in abolishing pain during muscle traction which is usually a complain for many patients a reason to use systemic opioid intra operatively or even general anesthesia

Conditions

Interventions

DRUG

Fentanyl

50 mic fentanyl added as an adjuvant

Sponsors & Collaborators

  • Research Institute of Ophthalmology, Egypt

    lead OTHER

Principal Investigators

  • Abeer S Salem, MD · Research Institute of Ophthalmology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2022-11-30
Completion
2022-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05539911 on ClinicalTrials.gov